We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$632M
AUM Growth
-$24.2M
Cap. Flow
-$29.9M
Cap. Flow %
-4.73%
Top 10 Hldgs %
19.9%
Holding
333
New
27
Increased
83
Reduced
86
Closed
28

Top Buys

Rank Stock Value
1
NVCR icon
NovoCure
NVCR
+$5.65M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
+$4.32M
3
MG icon
Mistras Group
MG
+$3.88M
4
RSKD icon
Riskified
RSKD
+$3.56M
5
MITK icon
Mitek Systems
MITK
+$3.41M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$10.3M
2
BBNX
Beta Bionics
BBNX
+$6.64M
3
UVE icon
Universal Insurance Holdings
UVE
+$6M
4
STRL icon
Sterling Infrastructure
STRL
+$4.94M
5
AGX icon
Argan
AGX
+$4.7M

Sector Composition

Rank Sector Weight
1 Industrials 28.14%
2 Technology 24.71%
3 Healthcare 23.43%
4 Financials 5.67%
5 Consumer Staples 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
51
Jazz Pharmaceuticals
JAZZ
$16.7B
$4.12M 0.65%
21,778
-1,417
-6% -$248K
PKE icon
52
Park Aerospace
PKE
$810M
$4.1M 0.65%
149,893
+2,645
+2% +$67.7K
MG icon
53
Mistras Group
MG
$498M
$3.97M 0.63%
+268,567
New +$3.88M
SMTC icon
54
Semtech
SMTC
$12.6B
$3.89M 0.62%
50,644
+937
+2% +$77.1K
IDN icon
55
Intellicheck
IDN
$76.8M
$3.76M 0.6%
537,842
+215,949
+67% +$1.17M
MITK icon
56
Mitek Systems
MITK
$759M
$3.72M 0.59%
+275,602
New +$3.41M
MRVL icon
57
Marvell Technology
MRVL
$189B
$3.59M 0.57%
+36,203
New +$3.04M
DAKT icon
58
Daktronics
DAKT
$1.05B
$3.56M 0.56%
182,086
+3,210
+2% +$73.3K
AGIO icon
59
Agios Pharmaceuticals
AGIO
$1.91B
$3.49M 0.55%
+103,177
New +$2.93M
AMTB icon
60
Amerant Bancorp
AMTB
$1.14B
$3.46M 0.55%
156,818
+2,728
+2% +$58.6K
SOPH icon
61
SOPHiA GENETICS
SOPH
$561M
$3.43M 0.54%
+692,809
New +$3.37M
BKSY icon
62
BlackSky Technology
BKSY
$1.14B
$3.42M 0.54%
136,104
+2,408
+2% +$57.5K
GFF icon
63
Griffon
GFF
$4.88B
$3.42M 0.54%
47,076
+876
+2% +$71K
ARQT icon
64
Arcutis Biotherapeutics
ARQT
$3.31B
$3.39M 0.54%
143,934
+2,663
+2% +$68K
OUST icon
65
Ouster
OUST
$3.07B
$3.39M 0.54%
184,585
+3,259
+2% +$71K
EVER icon
66
EverQuote
EVER
$839M
$3.35M 0.53%
217,075
-14,349
-6% -$271K
BKR icon
67
Baker Hughes
BKR
$62.3B
$3.34M 0.53%
54,682
-4,010
-7% -$232K
DIOD icon
68
Diodes
DIOD
$4.54B
$3.34M 0.53%
+48,869
New +$3.08M
CRM icon
69
Salesforce
CRM
$153B
$3.33M 0.53%
17,854
-1,226
-6% -$254K
OCUL icon
70
Ocular Therapeutix
OCUL
$1.92B
$3.33M 0.53%
392,718
+6,893
+2% +$65.7K
APYX icon
71
Apyx Medical
APYX
$175M
$3.33M 0.53%
+901,398
New +$3.37M
LQDT icon
72
Liquidity Services
LQDT
$1.31B
$3.3M 0.52%
108,004
+1,916
+2% +$59.6K
BGC icon
73
BGC Group
BGC
$4.97B
$3.29M 0.52%
336,781
+6,272
+2% +$58.1K
DLTR icon
74
Dollar Tree
DLTR
$24.9B
$3.24M 0.51%
29,614
-2,163
-7% -$264K
CON
75
Concentra Group Holdings
CON
$3.91B
$3.21M 0.51%
149,625
-11,020
-7% -$245K
1 2
3
4 5

Similar funds

AMM
American Money Management Rancho Santa Fe, California $632M AUM 14.06% 1-Year Est. Return
WA
WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ACM
Arini Captial Management London, United Kingdom $634M AUM
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return

Essex Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Essex Investment Management held 333 positions worth $632M, down 3.7% from $656M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Essex Investment Management withdrew a net $29.9M in Q1 2026, closing 28 positions and reducing 86 holdings. Its most notable exit was Beta Bionics, an estimated $6.64M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Essex Investment Management opened a new position in NovoCure worth $4.93M.

  • Essex Investment Management's largest Q1 2026 buy was NovoCure: 452,370 shares worth $4.93M.
  • Essex Investment Management added most to Rapid Micro Biosystems in Q1 2026, an estimated $3.01M increase.
  • Essex Investment Management's biggest Q1 2026 reduction was Tower Semiconductor, cutting an estimated $10.3M.
  • Essex Investment Management fully exited Beta Bionics in Q1 2026, selling an estimated $6.64M.
  • Essex Investment Management's ten largest holdings make up 20% of its $632M portfolio in Q1 2026.
  • Essex Investment Management opened 27 new positions and closed 28 in Q1 2026.
  • Essex Investment Management's portfolio value fell 3.7% quarter-over-quarter to $632M.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.